Alto Neuroscience Inc.
ANRO | NYSE
$30.54
-$0.09 (-0.29%)
Sep 22, 2026, 2:24 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -84.24M | -74.31M | -63.24M | -62.26M | -64.86M | -63.18M | -61.43M | -57.45M | -49.81M | -42.44M | -36.31M | -32.74M | -23.6M | -14.94M | -7.65M |
Depreciation & Amortization | 689K | 674K | 661K | 674K | 645K | 589K | 515K | 437K | 365K | 364K | 353K | 358K | 295K | 183K | 97K |
Stock-Based Compensation | 8.57M | 7.02M | 6.16M | 7.73M | 7.54M | 7.42M | 7.63M | 6.67M | 5.21M | 4.59M | 2.89M | 3.23M | 2.69M | 1.43M | 941K |
Other Working Capital | 340K | -1.68M | -188K | -1.72M | -183K | 526K | 3.54M | 2.3M | 1.1M | -1.48M | -391K | -621K | -1.8M | -895K | -605K |
Other Non-Cash Items | 4.05M | 4.01M | 4.61M | 2.55M | 2.07M | 2.52M | 1.8M | 1.61M | 1.41M | 558K | 311K | -65K | -3K | -59K | -225K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 2.65M | 299K | 33K | -1.97M | -479K | -344K | 4.06M | 2.81M | 853K | 23K | -698K | 1.28M | 442K | -158K | 818K |
Operating Cash Flow | -68.29M | -62.3M | -51.77M | -53.27M | -55.08M | -53M | -47.42M | -45.93M | -41.97M | -36.91M | -33.45M | -27.95M | -20.18M | -13.55M | -6.02M |
Capital Expenditures | -556K | -556K | -24K | -530K | -1.54M | -1.88M | -2.08M | -1.92M | -959K | -673K | -470K | -180K | -137K | -83K | -62K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -556K | -556K | -24K | -530K | -1.54M | -1.88M | -2.08M | -1.92M | -959K | -673K | -470K | -180K | -137K | -83K | -62K |
Debt Repayment | 750K | 1.5M | 10.98M | 10.98M | 11.48M | 10.73M | 1.25M | 1.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 4.71M | -167K | -167K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 113.99M | -368K | -724K | -724K | -127K | -546K | -3.02M | -4.92M | -4.81M | -4.77M | -1.75M | 9.82M | 9.71M | 9.67M | 9.67M |
Financial Cash Flow | 165.01M | 165.89M | 60.08M | 9.94M | 11.11M | 10.26M | 135.69M | 178.77M | 177.51M | 177.69M | 68.13M | 44.71M | 44.66M | 44.71M | 19.71M |
Net Cash Flow | 96.15M | 103.01M | 8.26M | -43.89M | -45.54M | -44.64M | 86.18M | 130.91M | 134.59M | 140.12M | 34.2M | 16.59M | 24.33M | 31.09M | 13.65M |
Free Cash Flow | -68.84M | -62.86M | -51.79M | -53.8M | -56.62M | -54.87M | -49.5M | -47.85M | -42.93M | -37.58M | -33.92M | -28.13M | -20.32M | -13.63M | -6.08M |
Adj. Free Cash Flow | -77.41M | -69.88M | -57.96M | -61.53M | -64.15M | -62.29M | -57.13M | -54.52M | -48.14M | -42.17M | -36.81M | -31.35M | -23M | -15.05M | -7.02M |
Maintenance CapEx | -184K | -184K | -24K | -530K | -1.54M | -1.88M | -2.08M | -1.92M | -959K | -673K | -470K | -180K | n/a | n/a | n/a |
Growth CapEx | -372K | -372K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -68.47M | -62.49M | -51.79M | -53.8M | -56.62M | -54.87M | -49.5M | -47.85M | -42.93M | -37.58M | -33.92M | -28.13M | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ANRO